To include your compound in the COVID-19 Resource Center, submit it here.

Shanghai-Pfizer connection

Pfizer invests in partner Shanghai Pharma, which adds Hong Kong listing

Shanghai-Pfizer connection

Only a month after partnering with Shanghai Pharmaceutical Holding Co. Ltd. (HKSE:2607; Shanghai:601607), Pfizer Inc. last week participated in the Chinese pharma's HK$15.3 billion ($2 billion) offering and a new listing on the Hong

Read the full 359 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE